| Dr Suja John Mathai, MD | |
|
1245 Whitehorse Mercerville Rd, Suite 411,, Mercerville, NJ 08619-3831 | |
| (609) 581-2000 | |
| (609) 581-5450 |
| Full Name | Dr Suja John Mathai |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 25 Years |
| Location | 1245 Whitehorse Mercerville Rd, Mercerville, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356518187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 25MA08142600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Id Care Llc | 7719959998 | 104 |
News Archive
Ben-Gurion University of the Negev researchers have developed a new system to assess obstructive sleep apnea (OSA) severity while a patient is awake and analyze sleep-wake activity, using his or her smartphone.
In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin(R) (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 1 days ago
| Entity Name | Infectious Disease Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093777187 PECOS PAC ID: 2163499542 Enrollment ID: O20040915000048 |
News Archive
Ben-Gurion University of the Negev researchers have developed a new system to assess obstructive sleep apnea (OSA) severity while a patient is awake and analyze sleep-wake activity, using his or her smartphone.
In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin(R) (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 1 days ago
| Entity Name | Id Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639146277 PECOS PAC ID: 7719959998 Enrollment ID: O20101208000463 |
News Archive
Ben-Gurion University of the Negev researchers have developed a new system to assess obstructive sleep apnea (OSA) severity while a patient is awake and analyze sleep-wake activity, using his or her smartphone.
In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin(R) (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 1 days ago
| Entity Name | St Francis Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821553413 PECOS PAC ID: 1557694197 Enrollment ID: O20190613000047 |
News Archive
Ben-Gurion University of the Negev researchers have developed a new system to assess obstructive sleep apnea (OSA) severity while a patient is awake and analyze sleep-wake activity, using his or her smartphone.
In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin(R) (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suja John Mathai, MD 10 Highland Dr, Chester, NJ 07930-3226 Ph: (908) 879-8286 | Dr Suja John Mathai, MD 1245 Whitehorse Mercerville Rd, Suite 411,, Mercerville, NJ 08619-3831 Ph: (609) 581-2000 |
News Archive
Ben-Gurion University of the Negev researchers have developed a new system to assess obstructive sleep apnea (OSA) severity while a patient is awake and analyze sleep-wake activity, using his or her smartphone.
In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin(R) (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.
Researchers at Ruhr-Universität Bochum were the first ones to prove the existence of an olfactory receptor in pigment-producing cells in human skin, the so-called melanocytes. The team headed by Prof Dr Dr Dr habil. Hanns Hatt demonstrated that the violet-like scent Beta-Ionone can activate the receptor.
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
› Verified 1 days ago
Alexander S Carney, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 8 Quakerbridge Plz, Suite H, Mercerville, NJ 08619 Phone: 609-588-9044 Fax: 609-588-0168 | |
Hesham S. Soliman, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2400 Whitehorse Mercerville Rd, Mercerville, NJ 08619 Phone: 609-587-4778 Fax: 609-587-1202 | |
Dr. Syed Asif Husain, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1245 Whitehorse Mercerville Rd, Suite 411, Mercerville, NJ 08619 Phone: 609-581-2000 Fax: 609-581-5450 | |
Dr. Sheryl Ann Haber-kuo, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2312 Whitehorse Mercerville Rd, Suite #201, Mercerville, NJ 08619 Phone: 609-586-9566 Fax: 609-586-9055 | |
Tahir Farooq, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1245 Whitehorse Mercerville Rd, Suite 411, Mercerville, NJ 08619 Phone: 609-581-2000 Fax: 609-581-5450 | |
Dr. Jesse Joseph Stawicki, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Whitehorse Mercerville Rd, Suite 316 Bldg. C, Mercerville, NJ 08619 Phone: 609-581-5586 Fax: 609-581-5779 |